Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 495 participants.
Also called NCT01729559
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 495 participants
- Sponsor
- Registry
-
NCT01729559
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01729559. Randomized; single masking; primary purpose prevention. Start 2012-11 (registry gives no type); primary completion 2014-09 (actual). Results posted on 2016-07-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
- Condition
- Venous Thromboembolic Disease
- Condition
- Deep Vein Thrombosis
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- 5000 Units unfractionated Heparin Q 8 hr
- Intervention (Drug)
- 30mg enoxaparin Q12 hr
- Lead sponsor
- Scripps Health
Record details
- Record id
cardio:ct-nct01729559- Content hash
856d9686db33c4e7ed7d5667128a4cd230bdf6f04da63fe732c50cda6e98bf25